Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima‐Media Thickness in Patients With Cardiovascular Disease and/or Diabetes—A Systematic Review
The study suggests that prolonged use of Pioglitazone, Repaglinide and Alogliptin may significantly slow CIMT progression, improving cardiovascular risk management in patients with diabetes and/or cardiovascular disease. Further research is needed to understand the benefits and optimise oral hypoglycaemic treatment strategies for these patients.
Authors
- Farzam Sheikhzadeh Hesari (ORCID: https://orcid.org/0000-0002-5945-7393)
- Wael Tawfick (ORCID: https://orcid.org/0000-0002-4301-7406)
- Syed Yaseen Naqvi
- Syed Mohammad Naqvi (ORCID: https://orcid.org/0000-0003-3994-5549)
- Ali Shabu
Institutions
- Lund University (SE)
- Ollscoil na Gaillimhe – University of Galway (IE)
- University of Limerick (IE)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/edm2.70140
- Primary Topic
- Cardiovascular Health and Disease Prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00